Allergan's CEO Brent Saunders was quick to declare his company could move ahead without the merger, announcing a new R&D deal with Heptares in Alzheimer's disease. Unusually for a pharma chief ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to New ...

Novartis has joined with Allergan in a bid to get ahead in the race to get a drug approved to treat the fatty liver disease, non-alcoholic steatohepatitis (NASH). The Swiss pharma said it is to ...

Actavis CEO Brent Saunders 44, saw the deal through its close in March 2015, at which point he became the CEO of Allergan Plc - now a Dublin-based global pharmaceutical company. In July ...

$6,624,473 Brent Saunders has been presiding over Allergan and its billion-dollar Botox empire since 2014, when a $66 billion merger launched the company as a member of Big Pharma. Lately ...

Pharmaceutical giant AbbVie said Tuesday that it plans to acquire Botox-maker Allergan as it builds up its portfolio in the face of looming competition for its blockbuster medication Humira.

Dr Matthew Hickling explores the science behind beauty, his role in aesthetics and the opportunities shaping the future of the field.

Its comments came after the North Chicago, Illinois-based pharma giant posted a surprising ... Its Botox business added with its $63B Allergan buyout in 2020 exceeded Street forecasts, as net ...

Aptar Pharma has announced its multi-dose Ophthalmic Squeeze Dispenser has been selected for a dry eye prescription product in ...

During a recent lunch at the Farmhouse at Roger’s Garden, Gavin Herbert pointed to a key that enabled him to build Allergan – hiring.